Analyte and product boundary
Salivary melatonin rhythm test kits are collection-and-testing systems that obtain a series of saliva specimens on a planned schedule, measure melatonin in a laboratory, and estimate circadian phase; they are classified in WSIC 2.1.2. Salivary concentrations commonly track changes in blood melatonin, while collection is easier than repeated blood draws, making saliva useful for describing the evening rise. The kit is not a continuous monitor and does not directly measure total daily pineal output, sleep depth, or the quality of a particular night's sleep.
A “kit” may contain only tubes and labels, or it may bundle shipping, laboratory analysis, and a phase report. A collection device, an in vitro diagnostic reagent, a laboratory-developed test, and a wellness service do not necessarily have the same regulatory status. Before use, identify the ordering purpose, laboratory, analytical method, collection protocol, storage and transport conditions, rejection rules, and reporting units. A research or wellness-trend product must not automatically be treated as a validated disease diagnostic.
DLMO, single values, and the full curve
Dim light melatonin onset, or DLMO, is the time at which melatonin rises persistently from a low baseline to a prespecified threshold under controlled dim-light conditions. It is an important marker of central circadian phase. Estimating it requires a time-stamped series and a collection window that actually covers the rising portion of the profile. One morning, bedtime, or otherwise isolated concentration cannot determine DLMO, and a “high” or “low” value alone cannot diagnose a supposed melatonin deficiency.
The full profile shows whether a rise is clear, whether the collection window missed onset, and whether a result is reportable. A fixed-concentration threshold and a threshold calculated relative to the individual's baseline are different algorithms and can yield different onset times; the rule validated for that laboratory and method should be used. The phase angle between DLMO and habitual sleep onset can sometimes aid interpretation, but late sleep does not necessarily mean delayed circadian phase, and one late phase estimate is not a stand-alone diagnosis.
Clinical use and place in diagnosis
DLMO can support research or specialist assessment of circadian phase and may help select or monitor phase-timed interventions in contexts such as delayed sleep-wake phase disorder, advanced sleep-wake phase disorder, and non-24-hour sleep-wake rhythm disorder. It can also be used to assess the effect of light on circadian timing. Its value depends on asking a genuine circadian-phase question, not merely on the presence of insomnia, fatigue, or daytime sleepiness.
Diagnosis of a circadian rhythm sleep-wake disorder still centers on sleep history, schedule regularity, sleep diaries, and actigraphy when appropriate, while considering shift work, jet lag, insufficient sleep, medicines, psychiatric conditions, and medical illness. DLMO is not required by every formal diagnostic pathway. It cannot by itself diagnose insomnia, depression, sleep apnea, pineal disease, or the severity of jet lag, and it does not replace polysomnography or clinical risk assessment.
Dim light, the sampling clock, and adherence
Ambient light is part of the measurement condition. Ordinary room lighting and light from a phone or another screen can suppress or delay the melatonin rise, so the measured time may no longer represent the underlying phase. Follow the testing laboratory's illuminance, light-source, and screen restrictions before and throughout collection. A room that merely “feels dim” does not establish compliance, and a lux limit taken from a different protocol is not a universal standard.
The collection window is generally planned from recent habitual bedtime, a sleep diary, or actigraphy rather than assigning the same clock times to everyone. Record the actual collection date and time on every tube and preserve the required interval and order. If a sample is missed or late, order is reversed, the dim environment is interrupted, or the window fails to capture the rise, document it and contact the laboratory. Do not invent a time, split one specimen among tubes, or use interpolation to manufacture a complete curve.
Oral conditions, substances, and specimen handling
Food residue, colored foods or drinks, water, toothbrushing, mouthwash, smoking, gingival bleeding, oral ulcers, and recent dental work can affect specimen quality. The waiting period after food or oral care, whether water is allowed, and the choice of passive drool versus a specified absorbent device must follow that laboratory's instructions. An ordinary cotton swab can create adsorption or interference bias with some assays and must not replace the supplied collector. Do not touch absorbent material with bare hands.
Melatonin supplements and combination products containing melatonin can make the endogenous rhythm uninterpretable. Prescription and nonprescription medicines, caffeine, and other substances that may alter melatonin production or measurement also need to be disclosed. Do not stop a medicine or change a dose for testing on your own; the ordering clinician and laboratory should decide whether to adjust the plan, reschedule collection, or label the result uninterpretable. Protect, refrigerate or freeze, pack, and return specimens exactly as the kit requires rather than applying another laboratory's stability window.
Analytical method, thresholds, and quality control
Melatonin concentrations in saliva are low, particularly during the day and before onset, so an assay needs adequate sensitivity and precision at low concentrations. Immunoassays are accessible but can have cross-reactivity and systematic differences between methods; liquid chromatography-tandem mass spectrometry has different selectivity and calibration requirements. Results from different laboratories, collectors, lots, methods, or units cannot simply be joined, and a threshold found online or in another paper cannot be transplanted without validation.
A useful report identifies collection times, analytical method, limit of quantitation, the fixed or relative threshold used, the DLMO calculation rule, and relevant uncertainty. If the first specimen is already above threshold, no sustained rise occurs within the window, the baseline is too low, or specimens are contaminated, missing, or unreliably timed, the proper conclusion may be “not captured” or “indeterminate,” not “no melatonin.” An unusual or borderline profile should be reviewed with the raw time points and quality flags and repeated when clinically appropriate.
Interpretation, intervention, and safety boundaries
Interpret DLMO in the context of the individual's sleep timing, light history, work shifts, travel, medicines, and symptoms. Phase-timed light and melatonin can shift the clock in different directions at different circadian times; a test kit therefore cannot generate one universal light schedule, supplement dose, or administration time. A clinician experienced in circadian care should combine the goal, contraindications, feasibility, and follow-up measurements when designing treatment.
A normal result does not explain every case of insomnia or sleepiness, and an atypical result does not prove a single cause. Persistent schedule misalignment that impairs function, dangerous driving, or work-related sleepiness warrants timely clinical assessment. Clear mania, psychotic symptoms, thoughts of self-harm, or an immediate inability to remain awake requires appropriate emergency or crisis help rather than waiting for a mail-in result. The kit should not be used for self-diagnosis, unilateral medication changes, or claims that one test can “reset the body clock.”